Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ağustos 2024 | 0 |
| Eylül 2024 | 0 |
| Ekim 2024 | 0 |
| Kasım 2024 | 0 |
| Aralık 2024 | 0 |
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| Gursoy2022_Article_Real-lifeComparisonOfAfatinibA.pdf | 4 |
